CompletedPhase 4NCT02642653

Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, Davis
Principal Investigator
Randi J Hagerman, MD
UC Davis
Intervention
Lovastatin(drug)
Enrollment
30 enrolled
Eligibility
10-17 years · All sexes
Timeline
20162018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02642653 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials